The only cancer specialist library service in Wales. Supporting NHS and academic staff, students and health professionals throughout the Principality.
Cardiff
Joined March 2013
- Tweets21.1K
- Following2.3K
- Followers1.3K
- Likes167
🎶Oh the weather outside is frightful, but the @immunobuddies are so delightful...🎶 Episode 226: When Immunotherapy Meets A Transplanted Organ. @VelindreCS @RickyFrazer1 @AOlssonBrown open.spotify.com/episode/11g…
Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage #BreastCancer: The I-SPY2.2 Randomized Clinical Trial. jamanetwork.com/journals/jam…
The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology. annalsofoncology.org/article…
Gastric and oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. annalsofoncology.org/article…
Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative #BreastCancer: the HELEN-Trio 011 randomized clinical trial. annalsofoncology.org/article…
Nivolumab + relatlimab with platinum-doublet chemotherapy vs nivolumab with platinum-doublet chemotherapy in stage IV or recurrent non-small cell #LungCancer: clinical, translational, and patient-reported outcomes results- phase II RELATIVITY-104 study. annalsofoncology.org/article…
Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient #ColonCancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial. thelancet.com/journals/lance…
Clinical implications of germline and somatic genetic testing in ovarian carcinoma: BRCA and beyond. The PERSONA-Ovary trial. gynecologiconcology-online.n…
Phase I and early phase II study of enhancing immune checkpoint inhibitor efficacy using a Mycobacterium tuberculosis extract combined with radiation therapy in non-small cell #LungCancer patients: NEJ046A. lungcancerjournal.info/artic…
Feasibility of Real-Time Integration of a Large Language Model in the EHR to Identify Goals-of-Care Documentation. jpsmjournal.com/article/S088…
US-based Delphi Consensus Study on Adjuvant Radiation Therapy (ART) in Node-Negative Cutaneous Squamous Cell Carcinoma (CSCC). redjournal.org/article/S0360…
Organ Preservation With Total Neoadjuvant Therapy (OPTNT) for Early Low #RectalCancer: Short-Term Outcomes of a Nonrandomized Phase 2 Clinical Trial. redjournal.org/article/S0360…
How to plan and deliver #LungCancer reirradiation: A consensus approach from the ESTRO reirradiation and lung focus groups and ReCOG. thegreenjournal.com/article/…
Harmonizing spatially fractionated radiation therapy: consensus and roadmap from an ESTRO workshop. thegreenjournal.com/article/…
Carbon ion radiotherapy for non-metastatic #PancreaticCancer: final results of the prospective phase 2 PACK-study (NCT04194268). thegreenjournal.com/article/…
Cardiovascular Toxicity Across the #Cancer Immunotherapy Spectrum: Mechanisms and Management in Immune Checkpoint Inhibitor (ICI) and Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. @RickyFrazer1 @VelindreCS link.springer.com/article/10…
NICE Technology Appraisal Guideline [TA1202]: Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic #BreastCancer after 1 or more lines of anti-HER2 treatment. @NICEComms nice.org.uk/guidance/ta1202
Impact of remote management using patient-reported outcomes on pain and anxiety after breast biopsy: the BIO-PSY randomized controlled trial. link.springer.com/article/10…
Bolus-only versus bolus plus continuous infusion hydromorphone for refractory #Cancer pain: a prospective, multicenter, randomized noninferiority trial. link.springer.com/article/10…
Cobimetinib + Vemurafenib in Patients With BRAF V600E–Mutant Papillary Thyroid and Biliary Tract #Cancers: Results From the TAPUR Study. ascopubs.org/doi/10.1200/PO-…
